Most Read Articles
Elaine Soliven, 20 Apr 2018
The use of high-flow oxygen therapy may reduce the need for escalation of care in infants with bronchiolitis compared with standard oxygen therapy, according to a recent study.

Efficacy of dual bronchodilators therapy and inhaler devices for COPD management - can ANORO® help your COPD patients?

04 Aug 2017
Dato' Dr Hj Abdul Razak Abdul Muttalif

Chronic obstructive pulmonary disease (COPD) is the fourth cause of global mortality, with experts predicting a potential future rise in the prevalence rates of COPD.
At a recent expert discussion during the Malaysian Thoracic Society (MTS) Congress 2017, Dato' Dr Abdul Razak Abdul Muttalif and Dr Ahmad Izuanuddin provided insights on the current landscape of COPD in Malaysia and the role of dual bronchodilators such as umeclidinium/vilanterol in the management of COPD. Find out more about the use of ANORO® in the treatment of COPD in our upcoming symposium highlight article. 

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 20 Apr 2018
The use of high-flow oxygen therapy may reduce the need for escalation of care in infants with bronchiolitis compared with standard oxygen therapy, according to a recent study.